BioCentury
ARTICLE | Company News

KS Biomedix licenses antibodies to York Medical

November 2, 2000 8:00 AM UTC

York Medical received a license to co-develop KH-6H9Chi, an antibody to treat colon cancer from KS Biomedix (LSE:KSB). York will have the right to commercialize the product in the Americas, while KSB ...